3628 results for «86»

Filter By

3628 results

Our patient with a highly calcified vessel

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to define a step-by-step strategy to deal with calcified lesions, discover how OCT can support your decision making and to learn how to learn how to use ROTABLATOR for an effective and safe plaque debulking.

Our patient with a highly calcified vessel

The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...

19 Nov 2023 – From PCR London Valves 2023

Discover the top late-breaking trials which were presented during PCR London Valves 2023:

  • TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
  • Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
  • Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
  • Artificial intelligence derived risk...
PCR London Valves 2023 Top Late-Breaking Trials

Bifurcation PCI with provisional technique

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to learn how to assess bifurcation lesions, to get familiar with the steps of provisional approach and to understand causes and solutions for the most common pitfalls.

Bifurcation pci with provisional 

The catheter-based treatment revolution is just getting started

19 Nov 2023 – From PCR London Valves 2023

Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.

The catheter-based treatment revolution is just getting started

TAVI outcomes - Part 1

19 Nov 2023 – From PCR London Valves 2023

Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...

TAVI outcomes - Part 1

TAVI and beyond: tackling coronary challenges

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain a comprehensive understanding of the crucial role of coronary access post-TAVI, and the impact of TAV design and implantation technique on coronary access. Gain some insights into the intricacies of coronary accessibility from extensive bench test work and the impact of TAV design in...

TAVI and beyond: tackling coronary challenges

TAVI failure - Mechanisms and management

19 Nov 2023 – From PCR London Valves 2023

Explore various cases that focus on TAVI failure, including the effects of the mechanism of TAVR failure on outcomes after re-intervention, the prognostic impact of patient-prosthesis mismatch and paravalvular leak following TAVI, issues related to bioprosthetic valve dysfunction and much more!

TAVI failure - Mechanisms and management

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

19 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to understand the challenges of imaging for aortic regurgitation and how it can lead to underdiagnosis. Discover the data from the ALIGN-AR trial studying TAVI in aortic regurgitation patients, and learn about the Trilogy valve and the future of TAVI...

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

Valve performance and durability - Main considerations in selecting the right TAVI valve

20 Nov 2023 – From PCR London Valves 2023

In this session with LIVE case, participants discuss the critical role of valve selection in influencing patient outcomes. The focus includes understanding the latest clinical outcomes of supra-annular TAVI and SAVR, exploring their practical implications. The session also highlights the contribution of novel technology Evolut FX, in...

Valve performance and durability - Main considerations in selecting the right TAVI valve

Prevention and treatment of left ventricular outflow tract obstruction

19 Nov 2023 – From PCR London Valves 2023

Explore intriguing cases in this session and gain a deeper understanding of preventing and managing LVOT obstruction: uncover innovative approaches such as Valve-in-Valve TMVR with Lampoon, learn about the nuances of TMVR after re-section of the anterior leaflet, and more!

Prevention and treatment of left ventricular outflow tract obstruction

TAVI with challenging femoral access

19 Nov 2023 – From PCR London Valves 2023

Learn how to perform transfemoral TAVI using orbital atherectomy, insert a self-expanding valve through a tortuous and calcified aorta, or navigate through calcified vessels or kinked aorta thanks to the techniques presented in this session, among others.

TAVI with challenging femoral access

The EVOQUE and PASCAL Precision systems in action: simulation- and case-based learning

20 Nov 2023 – From PCR London Valves 2023

This session explores the features of the PASCAL Precision and the EVOQUE tricuspid replacement systems through simulators and case presentations, while a panel of experts discuss the technology, witnessing live demonstrations of treating mitral and tricuspid regurgitation patients.

The EVOQUE and PASCAL

Mitral valve interventions for complex anatomy

17 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session on to learn more about how to manage complex anatomy and complications during mitral valve interventions. Discover compelling cases such as a valve-in-ring TMVR in a fluoroscopically invisible ring, PASCAL for bailout of MitraClip single-leaflet device attachment, and more!

TAVI for patients with concomitant coronary artery disease - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...

TAVI for patients with concomitant coronary artery disease - LIVE case

Rapid-fire - Complex procedure in TAVI - Part 1

17 Feb 2024 – From PCR Tokyo Valves 2024

In the first part of this rapid-fire session, we focus on complex cases that might arise during TAVI, such as how to navigate a permanent pacemaker implantation, TAVI in a post-liver transplant patient with severe aortic regurgitation, or complex TAVI by transcarotid access.

PCR Tokyo Valves 2024 Welcome Ceremony

17 Feb 2024 – From PCR Tokyo Valves 2024

After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...

PCR Tokyo Valves 2024 Welcome Ceremony

Rapid-fire - Complications of Mitral TEER - Part 1

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases. Learn about what might cause a loud rumbling sound after intervention, and explore a rare complication of the MitraClip procedure. 

Challenges in TEER for secondary mitral regurgitation

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...

Challenges in TEER for secondary mitral regurgitation

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

The optimal first valve

How to optimise lifetime management of TAVI patients with long life expectancy?

17 Feb 2024 – From PCR Tokyo Valves 2024

In this special session sponsored by Abbott, gain insight into how valve design and features may influence clinical outcomes and future interventions. Learn about hemodynamic efficiency of TAVI valves, and understand the factors influencing durability and clinical performance over time.

Didn’t find what you were looking for?